NEW YORK, Feb. 26, 2021 /PRNewswire/ --Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm ratedA
Top 50A in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at theA Empire State BuildingA in New York City, is investigating
A Longevity Acquisition Corp. ("LOAC" or the "Company") (LOAC)A relating to its proposed merger with 4D Pharma PLC. Under the terms of the agreement, LOAC shareholders will receive 7.5315 shares of 4D Pharma per share.The investigation focuses on whether Longevity Acquisition Corp. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.
Click here for more information: https://monteverdelaw.com/case/longevity-acquisition-corp. It is free and there is no cost or obligation to you.
